sbv Improver diagnostic signature challenge: Preface to this special issue

Systems Biomedicine

Volumn 1, Issue 4, 2014, Pages 193-195

  Hoeng, Julia ^a   Stolovitzky, Gustavo ^b   Peitsch, Manuel C ^a  

^a PHILIP MORRIS PRODUCTS S A   (Switzerland)

^b IBM T J WATSON RESEARCH CENTER   (United States)

Author keywords

sbv Improver

Indexed keywords

MESSENGER RNA;

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DIAGNOSTIC PROCEDURE; GENE EXPRESSION; LUNG CANCER; METHODOLOGY; MICROARRAY ANALYSIS; MULTIPLE SCLEROSIS; PHENOTYPE; PSORIASIS; SBV IMPROVER; SYSTEMS BIOLOGY;

EID: 85043216720     PISSN: 21628130     EISSN: 21628149     Source Type: Journal    
DOI: 10.4161/sysb.26324     Document Type: Article

References (15)

1. Meyer P, Hoeng J, Rice JJ, Norel R, Sprengel J, Stolle K, Bonk T, Corthesy S, Royyuru A, Peitsch MC, et al. Industrial methodology for process verification in research (IMPROVER): toward systems biology verification. Bioinformatics 2012; 28:1193-201; PMID:22423044; http://dx.doi.org/10.1093/bioinformatics/bts116
2. Meyer P, Alexopoulos LG, Bonk T, Califano A, Cho CR, de la Fuente A, de Graaf D, Hartemink AJ, Hoeng J, Ivanov NV, et al. Verification of systems biology research in the age of collaborative competition. Nat Biotechnol 2011; 29:811-5; PMID:21904331; http://dx.doi.org/10.1038/nbt.1968
3. Rhrissorrakrai K, Rice JJ, Boue S, Talikka M, Bilal E, Martin F, Meyer P, Norel R, Xiang Y, Stolovitzky G, et al. sbv IMPROVER Diagnostic Signature Challenge: Design and results. Systems Biomedicine 2013; e26325
4. Norel R, Bilal E, Conrad-Chemineau N, Bonneau R, de la Fuente A, Jurisica I, Marbach D, Meyer P, Rice JJ, Tuller T, et al. sbv IMPROVER Diagnostic Signature Challenge: Scoring strategies. Systems Biomedicine 2013; e26326
5. Ioannidis JPA. Microarrays and molecular research: noise discovery? Lancet 2005; 365:454-5; PMID:15705441
6. Goozner M. Duke scandal highlights need for genomics research criteria. J Natl Cancer Inst 2011; 103:916-7; PMID:21693754; http://dx.doi. org/10.1093/jnci/djr231
7. Tarca AL, Lauria M, Unger M, Bilal E, Boue S, Dey KK, Hoeng J, Koeppl H, Martin F, Meyer P, et al.; IMPROVER DSC Collaborators. Strengths and limitations of microarray-based phenotype prediction: Lessons learned from the IMPROVER Diagnostic Signature Challenge. Bioinformatics 2013; In press; PMID:23966112; http://dx.doi. org/10.1093/bioinformatics/btt492
8. Tarca AL, Than NG, Romero R. Methodological approach from the Best Overall Team in the sbv IMPROVER Diagnostic Signature Challenge. Systems Biomedicine 2013; e25980
9. Lauria M. Rank-based transcriptional signatures: A novel approach to diagnostic biomarker definition and analysis. Systems Biomedicine 2013; e25982
10. Zhao C, Deshwar AG, Morris Q. Relapsing-remitting multiple sclerosis classification using elastic net logistic regression on gene expression data. Systems Biomedicine 2013; e26131
11. Nandy P, Unger M, Zechner C, Dey KK, Koeppl H. Learning diagnostic signatures from microarray data using L1-regularized logistic regression. Systems Biomedicine 2013; e25271
12. Cho J-H, Lin A, Wang K. Kernel-based method for feature selection and disease diagnosis using transcriptomics data. Systems Biomedicine 2013; e25978
13. Ben-Hamo R, Boue S, Martin F, Talikka M, Efroni S. Classification of lung adenocarcinoma and squamous cell carcinoma samples based on their gene expression profile in the sbv IMPROVER Diagnostic Signature Challenge. Systems Biomedicine 2013; e25983
14. Tian S, Suárez-Fariñas M. Hierarchical-TGDR: Combining biological hierarchy with a regularization method for multi-class classification of lung cancer samples via high-throughput gene-expression data. Systems Biomedicine 2013; e25979
15. Song L, Horvath S. Predicting COPD status with a random generalized linear model. Systems Biomedicine 2013; e25981